Lab-Developed Tests: FDA Gives Extra Time For Input On Oversight Plan
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to accept feedback through Sept. 15 on its ongoing efforts to develop a regulatory framework for tests developed and offered as services by clinical laboratories